Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
RVMD
RVMD News & Events
-
Add to Watchlist
Trade RVMD
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
RVMD News
Revolution Medicines Q1 2026 Earnings Call Insights
May 07 2026
seekingalpha
Revolution (RVMD) Q1 2026 Earnings Transcript
May 06 2026
NASDAQ.COM
Revolution Medicines Reports Clinical Trial Results for Daraxonrasib
May 06 2026
Newsfilter
Analysis of XBI ETF Trading Dynamics
May 06 2026
NASDAQ.COM
Revolution Medicines, Inc. Gains Attention for Huge Upside Potential
May 02 2026
Yahoo Finance
FDA Approves Revolution Medicines' Cancer Therapy for Expanded Access
May 01 2026
seekingalpha
Erasca's Cancer Drug Trial Data Triggers Stock Plunge
Apr 28 2026
seekingalpha
Erasca's Cancer Therapy Trial Reports Treatment-Related Death
Apr 28 2026
stocktwits
Show More News
RVMD Events
No data
RVMD Monitor News
Revolution Medicines stock declines amid market weakness
May 15 2026
Revolution Medicines Reports Positive Trial Results for Daraxonrasib
May 07 2026
Revolution Medicines Gains Attention for Breakthrough Cancer Therapy
May 04 2026
Revolution Medicines Reports Positive Clinical Data for Daraxonrasib
Apr 28 2026
Revolution Medicines Reports Updated Clinical Data for Zoldonrasib
Apr 23 2026
Revolution Medicines Reports Updated Clinical Data for Zoldonrasib
Apr 22 2026
Revolution Medicines Raises $1.5 Billion to Boost R&D Efforts
Apr 15 2026
Revolution Medicines' Drug Achieves Phase 3 Success, Stock Hits All-Time High
Apr 14 2026
Show More Monitor News
RVMD Earnings Analysis
Revolution Medicines Earnings: Strategic Growth Q3 2025- Intellectia AI™
6 months ago
People Also Watch
